These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effects of tramadol on static and dynamic pupillometry in healthy subjects--the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status. Fliegert F, Kurth B, Göhler K. Eur J Clin Pharmacol; 2005 Jun; 61(4):257-66. PubMed ID: 15906019 [Abstract] [Full Text] [Related]
5. Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans. Fromm MF, Hofmann U, Griese EU, Mikus G. Clin Pharmacol Ther; 1995 Oct; 58(4):374-82. PubMed ID: 7586928 [Abstract] [Full Text] [Related]
6. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation. Eckhardt K, Li S, Ammon S, Schänzle G, Mikus G, Eichelbaum M. Pain; 1998 May; 76(1-2):27-33. PubMed ID: 9696456 [Abstract] [Full Text] [Related]
7. Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysis. Webb JA, Rostami-Hodjegan A, Abdul-Manap R, Hofmann U, Mikus G, Kamali F. Br J Clin Pharmacol; 2001 Jul; 52(1):35-43. PubMed ID: 11453888 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Kirchheiner J, Schmidt H, Tzvetkov M, Keulen JT, Lötsch J, Roots I, Brockmöller J. Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548 [Abstract] [Full Text] [Related]
16. Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolites. Lötsch J, Skarke C, Schmidt H, Rohrbacher M, Hofmann U, Schwab M, Geisslinger G. Clin Pharmacol Ther; 2006 Jan; 79(1):35-48. PubMed ID: 16413240 [Abstract] [Full Text] [Related]
18. Dihydrocodeine Overdoses in a Neonate and in a 14-year-old Girl Who Were Both Genotyped as Cytochrome P450 2D6*1/*10-*36: Comparing Developmental Ages and Drug Monitoring Data With the Results of Pharmacokinetic Modeling. Shimizu M, Kondo T, Fukuoka T, Tanaka T, Yamazaki H. Ther Drug Monit; 2018 Apr; 40(2):162-165. PubMed ID: 29389842 [Abstract] [Full Text] [Related]